IceCure Medical
ICCM
17 hedge funds and large institutions have $247K invested in IceCure Medical in 2025 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 2 closing their positions.
200% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 2
61% more capital invested
Capital invested by funds: $154K → $247K (+$93.2K)
31% more funds holding
Funds holding: 13 → 17 (+4)
0.01% more ownership
Funds ownership: 0.01% → 0.01% (+0.01%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$56.3K |
| 2 |
TSS
Two Sigma Securities
New York
|
+$27.2K |
| 3 |
GCM
Gunderson Capital Management
Mt. Pleasant,
South Carolina
|
+$21.5K |
| 4 |
HF
HRT Financial
New York
|
+$18K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$13.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$26K |
| 2 |
Fisher Asset Management
Camas,
Washington
|
-$13.3K |
ICCM Hedge Fund Activity: Q2 2025 in Review
17 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in IceCure Medical (ICCM) for Q2 2025, worth a combined $247K — up 61% from $154K a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new ICCM positions and 2 closed out — a net gain of 4 holders — while 3 added to existing stakes and 0 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $56.3K. The largest seller was XTX Topco, exiting entirely with an estimated $26K sold.
- 17 institutional investors held IceCure Medical (ICCM) as of Q2 2025, up from 13 in Q1 2025.
- Funds reported $247K of IceCure Medical stock for Q2 2025, up 61% quarter-over-quarter.
- 6 funds opened new IceCure Medical positions in Q2 2025 and 2 closed out, a net change of +4 holders.
- The largest IceCure Medical buyer in Q2 2025 was Citadel Advisors, an estimated $56.3K added.
- The largest IceCure Medical seller in Q2 2025 was XTX Topco, an estimated $26K sold.
Based on aggregated 13F filings for Q2 2025.